Novartis Scemblix granted FDA Priority Review for the treatment of adults with newly diagnosed CML Read more
Bayer announces positive topline results for NUBEQA (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC) Read more
Merck Begins Commercial Production of First GMP-Compliant Manufacturing Line for Cell Culture Media in China Read more
Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with acquisition of Yellow Jersey Therapeutics Read more
Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD) Read more
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRPa cancer immunology treatment BI 770371 Read more